Primary aldosteronism is a curable cause of hypertension if the hypertension is due to an aldosterone-producing adenoma (APA) [1Funder J.W., Carey R.M., Mantero F., Murad M.H., Reincke M., Shibata H., y al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline J Clin Endocrinol Metab 2016 ; [jc20154061].

Haga clic aquí para ir a la sección de Referencias, 2Brown M.J. Primary Aldosteronism: the spectre of cure Clin Endocrinol (Oxf) 2015 ;  82 : 785-788 [cross-ref]

Haga clic aquí para ir a la sección de Referencias]. The discovery of somatic mutations defining pathogenetic subtypes of this adenoma has increased recognition of common but small zona glomerulosa-like APAs [3Azizan E.A., Poulsen H., Tuluc P., Zhou J., Clausen M.V., Lieb A., y al. Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension Nat Genet 2013 ;  45 : 1055-1060 [cross-ref]

Haga clic aquí para ir a la sección de Referencias, 4Choi M., Scholl U.I., Yue P., Bjorklund P., Zhao B., Nelson-Williams C., y al. K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension Science 2011 ;  331 : 768-772 [cross-ref]

Haga clic aquí para ir a la sección de Referencias, 5Azizan E.A., Lam B., Newhouse S., Zhou J., Clarke J., Happerfield L., y al. Microarray, qPCR and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors J Clin Endocrinol Metab 2012 ;  97 : E819-E829

Haga clic aquí para ir a la sección de Referencias, 6Akerstrom T., Willenberg H.S., Cupisti K., Ip J., Backman S., Moser A., y al. Novel somatic mutations and distinct molecular signature in aldosterone-producing adenomas Endocr Relat Cancer 2015 ;  22 : 735-744 [cross-ref]

Haga clic aquí para ir a la sección de Referencias]. In this subtype, we have sought APAs with distinctive presentation or outcome, in which analysis of genotype–phenotype associations could help explain the low success rate and variability of adrenalectomy for curing hypertension.

Ten zona glomerulosa-like APAs from three women with primary aldosteronism were analysed by exome sequencing and microarray analysis. Nine had a mutation of ATP1A1 or CACNA1D, and one had a distinctive genotype and transcriptome. Targeted sequencing of further zona glomerulosa-like APAs led to the finding of two with a similar genotype, and to the recognition that all three women presented in early pregnancy or menopause. Quantitative PCR and immunohistochemistry were performed for genes upregulated in the index case. Similar analyses and a TCF–LEF assay for Wnt signalling were performed on cells transfected with the mutant gene.

All three APAs had novel mutations in exon 3 of CTNNB1, encoding β-catenin in the Wnt cell-differentiation pathway. The mutations prevented phosphorylation of β-catenin, resulting in an increase in total form of β-catenin and active to total ratio, as quantified by immunoblotting. Transfection of mutant constructs into HEK cells caused near doubling of Wnt signalling in a luciferase reporter assay. Microarray of the index case found a greater than 100-fold increase in expression of gonadal receptors LHCGR and GNRHR, confirmed by qPCR (both genes) and immunohistochemistry (LHCGR) in all three APAs. Increased GATA4 expression was further evidence of adrenocortical cell de-differentiation towards their common gonad-adrenal precursor cell-type. Transfection of LHCGR-negative APA cells with GFP-mutant-CTNNB1 switched on LHCGR expression in GFP-positive cells.

The role of the Wnt system in adrenal physiology and tumour development is well recognised [7Berthon A., Drelon C., Ragazzon B., Boulkroun S., Tissier F., Amar L., y al. WNT/beta-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production Hum Mol Genet 2014 ;  23 : 889-905 [cross-ref]

Haga clic aquí para ir a la sección de Referencias, 8Berthon A., Martinez A., Bertherat J., Val P. Wnt/beta-catenin signalling in adrenal physiology and tumour development Mol Cell Endocrinol 2012 ;  351 : 87-95 [cross-ref]

Haga clic aquí para ir a la sección de Referencias]. De-differentiation of zona glomerulosa-cells after Wnt activation by the CTNNB1 mutation seems to cause aberrant gonadal receptor expression, which is also previously described [9Saner-Amigh K., Mayhew B.A., Mantero F., Schiavi F., White P.C., Rao C.V., y al. Elevated expression of luteinizing hormone receptor in aldosterone-producing adenomas J Clin Endocrinol Metab 2006 ;  91 : 1136-1142 [cross-ref]

Haga clic aquí para ir a la sección de Referencias, 10Albiger N.M., Sartorato P., Mariniello B., Iacobone M., Finco I., Fassina A., y al. A case of primary aldosteronism in pregnancy: do LH and GNRH receptors have a potential role in regulating aldosterone secretion? Eur J Endocrinol 2011 ;  164 : 405-412 [cross-ref]

Haga clic aquí para ir a la sección de Referencias]. Our findings connect these observations, and explain the unmasking of small APAs by increases in luteinising hormone and human chorionic gonadotropin hormone in early pregnancy or menopause. Strikingly, all three women, including the treatment-resistant older woman, were clinically cured by adrenalectomy. This contrasts with the failure of adrenalectomy to completely cure hypertension in the majority of patients. This failure is attributable to decades of exposure to aldosterone excess, and the secondary consequences of fibrosis and remodelling in the cardiovascular system [11Lang F. On the pleotropic actions of mineralocorticoids Nephron Physiol 2014 ;  128 : 1-7 [inter-ref]

Haga clic aquí para ir a la sección de Referencias, 12Reil J.C., Hohl M., Selejan S., Lipp P., Drautz F., Kazakow A., y al. Aldosterone promotes atrial fibrillation Eur Heart J 2012 ;  33 : 2098-2108 [cross-ref]

Haga clic aquí para ir a la sección de Referencias]. CTNNB1 mutations have now been reported in 10% of APAs without a previously reported mutation [13Akerstrom T., Maharjan R., Sven Willenberg H., Cupisti K., Ip J., Moser A., y al. Activating mutations in CTNNB1 in aldosterone producing adenomas Sci Rep 2016 ;  6 : 19546 [cross-ref]

Haga clic aquí para ir a la sección de Referencias]. Elucidation of APA subtypes could, with preoperative genotyping, permit recognition of patients in whom recent onset of primary aldosteronism is likely to be completely resolved by surgery.